InflaRx N.V. (IFRX) vs Profound Medical Corp. (PROF)

A side-by-side comparison of InflaRx N.V. and Profound Medical Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IFRX vs PROF

growth of $100 · dividends reinvested · last 7y
IFRX -35.6% (-6.1%/yr)PROF -37.9% (-6.6%/yr)IFRX compounded faster over this window
100200300Start $100202120232025$64$62
IFRX PROF

IFRX vs PROF: by the numbers

  • •IFRX is the larger company ($236M vs $223M market cap).
  • •Both run net losses; PROF's is the smaller (-171.72% vs -155582.08% net margin).

Metrics side by side

Valuation

MetricIFRXPROF
P/S ratioN/A11.72
P/B ratio1.414.47

Profitability

MetricIFRXPROF
Gross margin-24677.94%71.79%
Operating margin-164525.50%-256.27%
Net margin-155582.08%-171.72%
ROE-27.27%-65.59%
ROIC-25.38%-61.03%

Growth (annualized)

MetricIFRXPROF
Revenue CAGR (5Y)N/A16.55%
Total return CAGR (5Y)-7.34%-15.23%

Frequently asked

How have IFRX and PROF total returns compared?
Over the past 5 years, IFRX delivered -7.34% and PROF delivered -15.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.